Even though the shortage resolved in late 2024, Alka Menon, a sociologist at Yale University, said compounded GLP-1s continue to proliferate, with little oversight over the drugs themselves and the popular pathways for accessing them, like telehealth companies
The Mid-Day "Replenish" By lunch or mid-afternoon, your body has been working hard
This book fills that gap in a very practical, no-nonsense way
Retatrutide alone produced roughly 24% mean weight loss in its Phase 2 trial without any second agent
Pop-Busui R, Januzzi JL, Bruemmer D, Butalia S, Green JB, Horton WB, et al
While clinically validated, theyre more lifestyle supplement than magic bullet